Retrospective study investigated the effect sequence has on overall survival in patients with melanoma brain metastases treated with a combination of SRS, WBRT, immunotherapy, or targeted therapy.
Longer survival was achieved with stereotactic radiosurgery (SRS) alone than with whole-brain radiation therapy (WBRT) in patients with fewer than 4 brain metastases from NSCLC or breast cancer.
Radiosurgery and close monitoring is recommended to better preserve cognitive function in newly diagnosed brain metastases.
Overall survival was improved for adults age 50 years and younger with brain cancer who were treated with stereotactic radiosurgery that was not combined with whole-brain radiotherapy.
Tumor separation surgery followed by high-dose hypofractionated stereotactic radiosurgery (SRS) or high-dose single-fraction SRS is safe and effective in controlling spinal metastases regardless of the radiosensitivity of the particular tumor type that has invaded the spine.
Presentations on emerging standards of care in radiotherapy from the Future of Radiation Medicine 2011 symposium are reviewed.
External irradiation modalities can maximize radiation doses to tumor tissue while minimizing radiation dose to healthy tissues.
Survival rates increase for patients who are treated with Gamma Knife radiosurgery, according to results of a study presented at the American Society for Radiation Oncology (ASTRO) meeting in Chicago.
